[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
[ Fri, Oct 04th 2024 ]: WOPRAI
Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $11 on, Oct 4th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $13 to $11 on, Oct 4th, 2024.
Gregory has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, all agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Serge Belanger of "Needham" Downgraded from Strong Buy to Hold and Held Target at $12 on, Thursday, October 3rd, 2024
- Kemp Dolliver of "Brookline Capital" Downgraded from Strong Buy to Hold on, Wednesday, October 2nd, 2024